3E Bioventures Capital — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Aravivearavive.comOct 2022
BiotechHouston, US
Rudy Howard(Chief Financial Officer)Fredric N. Eshelman(Executive Chairman of the Board of Directors)Sigurd C. Kirk(Director)Michael W. Rogers(Director)Peter T.C. Ho(Director)Robert B. Geller(Chief Medical Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.